Anika Therapeutics (ANIK) Profit After Tax (2010 - 2026)
Anika Therapeutics (ANIK) posted quarterly Profit After Tax of $3.3 million for Q2 2026, up 171.21% year-over-year from $1.2 million in Q2 2025, and up 165.45% quarter-over-quarter from -$5.1 million in Q1 2026.
Anika Therapeutics (ANIK) Profit After Tax (2010 - 2026) Analysis & Trends
Anika Therapeutics (ANIK) has reported Profit After Tax for 17 consecutive years, with $3.3 million the latest figure, recorded in Q2 2026.
- In Q2 2026, Profit After Tax rose 171.21% year-over-year to $3.3 million; the TTM figure through Jun 2026 stood at -$4.0 million (up 93.53% YoY), while the FY2025 annual figure was -$10.9 million, up 80.99% from the prior year.
- Profit After Tax improved to $3.3 million in Q2 2026 per ANIK's latest filing, from -$5.1 million in the prior quarter.
- Across five years, Profit After Tax topped out at $3.3 million in Q2 2026 and bottomed at -$62.9 million in Q4 2023.
- Historically, Profit After Tax has averaged -$9.4 million across 5 years, with a median of -$4.6 million in 2024.
- Annual changes were most pronounced in 2025 — Profit After Tax slumped 5180.68% — and 2026, when it soared 171.21%.
- Anika Therapeutics' Profit After Tax stood at -$3.9 million in 2022, then plunged by 1531.53% to -$62.9 million in 2023, then surged by 63.89% to -$22.7 million in 2024, then surged by 103.96% to $900000.0 in 2025, then jumped by 267.67% to $3.3 million in 2026.
- Business Quant data shows ANIK's Profit After Tax at $3.3 million in Q2 2026, -$5.1 million in Q1 2026, and $900000.0 in Q4 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | PAT (Qtr) |
|---|---|---|---|---|---|
| 1 | Haleon | 43.76 Bn | 42.79 Bn | - | - |
| 2 | Teva Pharmaceutical Industries | 43.38 Bn | 39.73 Bn | 2.15 Bn | -576.00 Mn |
| 3 | Zoetis | 31.61 Bn | 29.93 Bn | 1.05 Bn | 866.00 Mn |
| 4 | Takeda Pharmaceutical | 28.64 Bn | 22.84 Bn | 5.10 Bn | 710.56 Mn |
| 5 | United Therapeutics | 22.20 Bn | 19.54 Bn | 683.80 Mn | 333.00 Mn |
| 6 | Viatris | 18.82 Bn | 17.93 Bn | 1.46 Bn | -118.80 Mn |
| 7 | Neurocrine Biosciences | 15.67 Bn | 15.28 Bn | 935.80 Mn | 149.10 Mn |
| 8 | Elanco Animal Health | 12.11 Bn | 11.58 Bn | 798.00 Mn | 54.00 Mn |
| 9 | Dr Reddys Laboratories | 10.10 Bn | 9.94 Bn | - | - |
| 10 | Anika Therapeutics | 285.86 Mn | 247.45 Mn | 21.24 Mn | 3.31 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | 3.31 Mn |
| Mar 31, 2026 | -5.06 Mn |
| Dec 31, 2025 | 900,000.00 |
| Sep 30, 2025 | -3.18 Mn |
| Jun 30, 2025 | -4.65 Mn |
| Mar 31, 2025 | -4.87 Mn |
| Dec 31, 2024 | -22.71 Mn |
| Sep 30, 2024 | -29.92 Mn |
| Jun 30, 2024 | -88,000.00 |
| Mar 31, 2024 | -4.51 Mn |
| Dec 31, 2023 | -62.88 Mn |
| Sep 30, 2023 | -6.98 Mn |
| Jun 30, 2023 | -2.74 Mn |
| Mar 31, 2023 | -10.35 Mn |
| Dec 31, 2022 | -3.85 Mn |
| Sep 30, 2022 | -5.03 Mn |
| Jun 30, 2022 | -2.84 Mn |
| Mar 31, 2022 | -2.93 Mn |
| Dec 31, 2021 | -5.79 Mn |
| Sep 30, 2021 | 757,000.00 |